Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)
Clinical trial NCT06674291 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06674291
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-30
- Primary completion
- 2027-12-31
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.